[Effect of long-term administration of clonidine on growth hormone secretion in hypertensive diabetics].
The anti-hypertensive effect of clonidine is closely related to its central alpha-agonist action. In acute administration, the drug provokes a significant increase in the plasma concentrations of growth hormone (GH). In chronic administration, the effects of clonidine on GH secretion are not well documented. Clonidine was administered at a daily dose of 0,15 to 0,30 mg to 10 non-obese diabetic hypertensive male subjects for at least 3 months. Blood glucose and GH plasma concentrations were determined 15 times during the 24-hour cycle. Blood glucose and GH values recorded before the intake and after stopping the drug, in the basal state, after meals, after measured muscular exercise and during the first stage of sleep could be superimposed when on and off clonidine. The effects of prolonged administration of clonidine on GH secretion thus differ markedly from the effects of acute administration as in non diabetic subjects. The long-term use of clonidine does not induce a chronic increase of GH plasma concentrations which might worsen the evolution of the diabetic microangiopathy.
D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D003000:Clonidine / Q000627:therapeutic use*; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000097:blood / Q000503:physiopathology*; D013006:Growth Hormone / Q000378:metabolism*; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged
D001786:Blood Glucose; D013006:Growth Hormone; D003000:Clonidine
Effets de la clonidine administreé au long cours sur la sécrétion d'hormone de croissance chez le diabétique hypertendu.